RE: PathFlow® Rapid LFT Range – Additional Revenues25 Jul 2021 15:01
Hi Porky,
Indeed knowing our partner is not that relevant, and in the end could be counter productive.
But there is the curiosité of human beeings haha.
But better not to shout to loud about it. If clients knows whos test it is, they could directly go to them.
Im still waiting on a Real launch RNS, with the Reach Service Platform, as for the 3G pcr.
And imo, the results forecast font take the LFTs into account.
If you look at the detailed forecast from numis, there is almost nothing for microgen. So we will have a nice surprise when Time Comes.
It's not the number of samples being similar, thats normal as you state. It is exactly the same S&S for both types of sampling. Saliva and NP.
But as said, if we dont know the name of the partner, its not a problem for me. We Never knew the partner for the ab lft, for our us oem, etc, it doesnt change anithing for me.